Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi.
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than ea...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2023-01-01
|
| Seri Bilgileri: | PLOS Global Public Health |
| Online Erişim: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0002057&type=printable |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|